MIR3659

gene
On this page

Also known as hsa-mir-3659

Summary

MIR3659 (microRNA 3659, HGNC:38882) is a microRNA gene on chromosome 1p34.3.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 100500801 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:38882
Approved symbolMIR3659
NamemicroRNA 3659
Location1p34.3
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-3659
Ensembl geneENSG00000265596
Ensembl biotypemiRNA
Entrez100500801
RNAcentralURS000075A969 — miRNA, 99 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000582606

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000582606 — 1 exons

ExonStartEnd
ENSE000027071883808923138089329

Expression profiles

Bgee: expression breadth broad, 44 present calls, max score 77.49.

Top tissues by expression

44 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
monocyteCL:000057677.49gold quality
bloodUBERON:000017875.88gold quality
skin of abdomenUBERON:000141672.23gold quality
heart left ventricleUBERON:000208472.19gold quality
lungUBERON:000204872.15gold quality
body of stomachUBERON:000116171.80gold quality
kidneyUBERON:000211371.59gold quality
gastrocnemiusUBERON:000138871.49gold quality
zone of skinUBERON:000001471.31gold quality
intestineUBERON:000016071.04gold quality
left adrenal gland cortexUBERON:003582571.02gold quality
skin of legUBERON:000151170.49gold quality
body of pancreasUBERON:000115070.40gold quality
myometriumUBERON:000129669.63gold quality
subcutaneous adipose tissueUBERON:000219069.45gold quality
left adrenal glandUBERON:000123469.33gold quality
nucleus accumbensUBERON:000188268.73gold quality
tibial arteryUBERON:000761068.44gold quality
transverse colonUBERON:000115768.42gold quality
muscle layer of sigmoid colonUBERON:003580568.19gold quality
vaginaUBERON:000099668.05gold quality
esophagogastric junction muscularis propriaUBERON:003584167.33gold quality
left lobe of thyroid glandUBERON:000112066.79gold quality
body of uterusUBERON:000985366.68gold quality
left ovaryUBERON:000211966.50gold quality
esophagus mucosaUBERON:000246966.48gold quality
dorsolateral prefrontal cortexUBERON:000983466.30gold quality
minor salivary glandUBERON:000183065.11gold quality
ascending aortaUBERON:000149665.02gold quality
prostate glandUBERON:000236764.94gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.16

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • Circulating miR-3659 may be a potential biomarker of dyslipidemia in patients with obesity. (PMID:30642348)
  • TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659. (PMID:34328265)
  • Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone. (PMID:35244999)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.